Physician profile
Jon J Atiga
NPI 1306831912
$697.28
in general payments reported to CMS, 2019-2025
13 companies · $226 in 2025
The $226 reported for 2025 was more than what 78% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.52 · 2020: $74.24 · 2021: $44.58 · 2022: $47.66 · 2023: $96.31 · 2024: $181 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $211.28 | 2020-2025 | |
| Cranial Technologies, INC | $183.47 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $57.27 | 2023-2025 | Rotarix, Bexsero |
| Pfizer INC. | $48.77 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $45.89 | 2025 | Ycanth |
| Phadia US INC. | $39.30 | 2024 | Immunocap |
| Collegium Pharmaceutical, INC. | $21.38 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $18.13 | 2025 | Gardasil 9, Vaxelis, M-M-R II |
| Kaleo, INC. | $17.51 | 2020 | |
| Alexion Pharmaceuticals, INC. | $15.74 | 2020 | |
| Lnhc, INC | $14.00 | 2025 | Zelsuvmi |
| Ironshore Pharmaceuticals INC. | $12.95 | 2019 | |
| Sobi, INC | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Atiga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.